ShareValue scores for 300244.SHE: Valuation 57, Quality 46, Growth 16, Health 36.

300244.SHE
SZSE

Zhejiang DiAn Diagnostics Co

CN¥19.75(+7.57%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 15%
Valuation
57
Fair Value
Price vs Value
Quality
46
Moderate
Business Strength
Growth
16
Weak
Revenue & Earnings
Health
36
Stressed
Financial Stability
Momentum
69
Bullish
Price Trend

Company Details

About

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus collection and preservation system; and multi-omics platform services. It also provides DP-TOF nucleic acid mass spectrometry solutions, including mass spectroscopy system, automatic sample processing system, respiratory pathogens multiple detection kit, and nucleic acid sample pretreatment reagent kit; and forensic drug testing products comprises diangio, hair drug trace tester and detector, and saliva and urine drug testing product series. In addition, the company offers diagnostic product supply, medical testing services, supply chain optimization, digital operation management, laboratory quality system construction, and professional cold chain logistics services. Further, it is involved in the research and development of diagnostic products; and vitro diagnostic reagents, as well as forensic identification, health management, and other fields. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 5, 2026
|
Last calculated:Aug 5, 2026